Edition:
United States

MEI Pharma Inc (MEIP.OQ)

MEIP.OQ on NASDAQ Stock Exchange Capital Market

3.46USD
18 May 2018
Change (% chg)

$0.22 (+6.63%)
Prev Close
$3.24
Open
$3.26
Day's High
$3.55
Day's Low
$3.25
Volume
121,778
Avg. Vol
38,000
52-wk High
$3.55
52-wk Low
$1.58

Select another date:

Wed, May 23 2018

BRIEF-Growth Equity Opportunities Fund V LLC Reports 9.99 Pct Stake In MEI Pharma Inc

* GROWTH EQUITY OPPORTUNITIES FUND V LLC REPORTS 9.99 PERCENT STAKE IN MEI PHARMA INC AS OF MAY 16 - SEC FILING Source text: (https://bit.ly/2IHP4lE) Further company coverage:

BRIEF-MEI Pharma Announces $75 Mln Private Placement

* MEI PHARMA INC - PROCEEDS FROM FINANCING WILL BE USED TO FUND CONTINUED CLINICAL DEVELOPMENT OF MEI-401

BRIEF-MEI Pharma Q3 Loss Per Share $0.16

* Q3 EARNINGS PER SHARE VIEW $-0.24 -- THOMSON REUTERS I/B/E/S

BRIEF-Mei Pharma Inc says ‍On Feb 22, Board Voted To Increase Size Of Board By One Seat

* MEI PHARMA INC - ‍ON FEBRUARY 22, 2018, BOARD OF CO VOTED TO INCREASE SIZE OF BOARD BY ONE SEAT -SEC FILING​ Source text - (http://bit.ly/2EUshBn) Further company coverage:

BRIEF-MEI Pharma Says Interim Data Review Supports Continuation Of ME-344 Clinical Study

* MEI PHARMA INTERIM DATA REVIEW SUPPORTS CONTINUATION OF CLINICAL STUDY EVALUATING ME-344 IN PATIENTS WITH BREAST CANCER

BRIEF-MEI Pharma Q2 Loss Per Share $0.16

* ‍AS OF DECEMBER 31, 2017, HAD $42.4 MILLION IN CASH, CASH EQUIVALENTS AND SHORT-TERM INVESTMENTS, WITH NO OUTSTANDING DEBT​

BRIEF-Helsinn Group and MEI Pharma's Pracinostat receives orphan drug designation from European Medicines Agency

* HELSINN GROUP AND MEI PHARMA ANNOUNCE THAT PRACINOSTAT HAS RECEIVED ORPHAN DRUG DESIGNATION FROM THE EUROPEAN MEDICINES AGENCY FOR THE TREATMENT OF ACUTE MYELOID LEUKEMIA (AML) Source text for Eikon: Further company coverage:

BRIEF-MEI Pharma Announces FDA Clearance Of Investigational New Drug Application For CDK Inhibitor Voruciclib

* MEI PHARMA ANNOUNCES FDA CLEARANCE OF INVESTIGATIONAL NEW DRUG APPLICATION FOR CDK INHIBITOR VORUCICLIB

Select another date: